These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 1970943)
1. Central action of psychomotor stimulants on glucose utilization in extrapyramidal motor areas of the rat brain. London ED; Wilkerson G; Ori C; Kimes AS Brain Res; 1990 Mar; 512(1):155-8. PubMed ID: 1970943 [TBL] [Abstract][Full Text] [Related]
2. Effects of methylenedioxymethamphetamine on local cerebral glucose utilization in the rat. Wilkerson G; London ED Neuropharmacology; 1989 Oct; 28(10):1129-38. PubMed ID: 2572994 [TBL] [Abstract][Full Text] [Related]
4. Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat. Spanos LJ; Yamamoto BK Pharmacol Biochem Behav; 1989 Apr; 32(4):835-40. PubMed ID: 2572003 [TBL] [Abstract][Full Text] [Related]
5. The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Yamamoto BK; Spanos LJ Eur J Pharmacol; 1988 Mar; 148(2):195-203. PubMed ID: 2897922 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine. Lorens SA; Hata N; Cabrera T; Hamilton ME NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039 [No Abstract] [Full Text] [Related]
10. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain. Gibb JW; Stone DM; Stahl DC; Hanson GR NIDA Res Monogr; 1987; 76():316-21. PubMed ID: 2449619 [TBL] [Abstract][Full Text] [Related]
12. Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats. Gold LH; Koob GF; Geyer MA J Pharmacol Exp Ther; 1988 Nov; 247(2):547-55. PubMed ID: 2903234 [TBL] [Abstract][Full Text] [Related]
13. Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Beardsley PM; Balster RL; Harris LS Drug Alcohol Depend; 1986 Oct; 18(2):149-57. PubMed ID: 2877842 [TBL] [Abstract][Full Text] [Related]
14. Behavioral suppression following 3,4-methylenenedioxymethamphetamine. Kulmala HK; Boja JW; Schechter MD Life Sci; 1987 Sep; 41(11):1425-9. PubMed ID: 2887995 [TBL] [Abstract][Full Text] [Related]
15. Effects of amphetamine analogs on central nervous system neuropeptide systems. Hanson GR; Sonsalla P; Letter A; Merchant KM; Johnson M; Bush L; Gibb JW NIDA Res Monogr; 1989; 94():259-69. PubMed ID: 2481828 [No Abstract] [Full Text] [Related]
16. Actions of amphetamine derivatives and cathinone at the noradrenaline transporter. Cleary L; Docherty JR Eur J Pharmacol; 2003 Aug; 476(1-2):31-4. PubMed ID: 12969746 [TBL] [Abstract][Full Text] [Related]
17. Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG). Dimpfel W; SpĆ¼ler M; Nichols DE Psychopharmacology (Berl); 1989; 98(3):297-303. PubMed ID: 2568652 [TBL] [Abstract][Full Text] [Related]
18. Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA. Rattray M Essays Biochem; 1991; 26():77-87. PubMed ID: 1685707 [No Abstract] [Full Text] [Related]
19. Effects of phencyclidine, ketamine and MDMA on complex operant behavior in monkeys. Thompson DM; Winsauer PJ; Mastropaolo J Pharmacol Biochem Behav; 1987 Feb; 26(2):401-5. PubMed ID: 2883665 [TBL] [Abstract][Full Text] [Related]
20. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline. Callahan PM; Appel JB J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]